ProfileGDS4718 / 1566157_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 62% 57% 68% 54% 55% 56% 73% 51% 59% 54% 50% 58% 55% 54% 57% 56% 55% 56% 54% 74% 61% 55% 59% 61% 52% 55% 49% 57% 56% 58% 53% 63% 56% 56% 55% 56% 73% 60% 56% 61% 56% 52% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0111558
GSM549102patient 115, normal, homogenized [OPG study]6.2413562
GSM549104patient 119, normal, homogenized [OPG study]5.9346857
GSM549108patient 138, normal, homogenized [OPG study]6.7011568
GSM549119patient 077, normal, homogenized [OPG study]5.7736354
GSM549133patient 032, cancer, homogenized [OPG study]5.767155
GSM549139patient 042, cancer, homogenized [OPG study]5.8588756
GSM549099patient 107, normal, homogenized [OPG study]7.0681373
GSM549109patient 139, normal, homogenized [OPG study]5.5948251
GSM549110patient 046, normal, homogenized [OPG study]6.0279759
GSM549114patient 063, normal, homogenized [OPG study]5.7111754
GSM549122patient 082, normal, homogenized [OPG study]5.5005150
GSM549134patient 033, cancer, homogenized [OPG study]5.9427858
GSM549136patient 036, cancer, homogenized [OPG study]5.7861555
GSM549140patient 044, cancer, homogenized [OPG study]5.7223454
GSM549111patient 047, normal, homogenized [OPG study]5.9023857
GSM549113patient 057, normal, homogenized [OPG study]5.8347656
GSM549132patient 031, cancer, homogenized [OPG study]5.8023355
GSM549137patient 038, cancer, homogenized [OPG study]5.888856
GSM549142patient 047, cancer, homogenized [OPG study]5.8944754
GSM549100patient 110, normal, homogenized [OPG study]7.2173674
GSM549107patient 135, normal, homogenized [OPG study]6.2016961
GSM549115patient 068, normal, homogenized [OPG study]5.7822355
GSM549116patient 072, normal, homogenized [OPG study]6.0552259
GSM549120patient 078, normal, homogenized [OPG study]6.1672761
GSM549131patient 030, cancer, homogenized [OPG study]5.5951252
GSM549118patient 074, normal, homogenized [OPG study]5.7889555
GSM549129patient 027, cancer, homogenized [OPG study]5.4797449
GSM549123patient 088, normal, homogenized [OPG study]5.9390857
GSM549124patient 006, cancer, homogenized [OPG study]5.8626956
GSM549126patient 015, cancer, homogenized [OPG study]5.9730958
GSM549128patient 025, cancer, homogenized [OPG study]5.6948853
GSM549103patient 117, normal, homogenized [OPG study]6.3040163
GSM549117patient 073, normal, homogenized [OPG study]5.7840556
GSM549138patient 041, cancer, homogenized [OPG study]5.8905656
GSM549141patient 045, cancer, homogenized [OPG study]5.7689155
GSM549130patient 028, cancer, homogenized [OPG study]5.8653856
GSM549101patient 111, normal, homogenized [OPG study]7.1090873
GSM549105patient 128, normal, homogenized [OPG study]6.1364960
GSM549106patient 134, normal, homogenized [OPG study]5.8360856
GSM549112patient 048, normal, homogenized [OPG study]6.1534161
GSM549125patient 011, cancer, homogenized [OPG study]5.8452856
GSM549127patient 024, cancer, homogenized [OPG study]5.6503752
GSM549135patient 035, cancer, homogenized [OPG study]5.7053154